Empagliflozin

Empagliflozin
21 August 2026

Empagliflozin

•    Drug Class: Anti Diabetic Type 2, SGLT2 inhibitors
•    Chemical Formula: C23H27ClO7
•    CAS Number: 864070-44-0
•    Indications: Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated:
-    To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.
-    To reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression.
-     To reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease. 
-     As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.

 

Add comment